CHICAGO and MINNEAPOLIS — Multistate operator Vireo Growth Inc. licensed the right to manufacture and distribute Curio Wellness’s Best Self Collection in New York. The portfolio includes topicals, tablets, chews and vapes. This capital-light growth model allows Curio to expand into one of the most promising markets in the country without the need for significant new investment, while Vireo enhances its portfolio with proven, high-demand offerings.
“We’re excited to bring Curio’s high-quality products to New York through this partnership,” said John Mazarakis, Chief Executive Officer of Vireo. “It’s a strong strategic fit that supports our focus on efficient growth and delivering premium offerings to our customers.”
Curio’s products have earned national recognition for both quality and consistency and are manufactured in compliance with Good Manufacturing Practices (GMP).
“This partnership is an exciting next step for our brand,” said Michael Bronfein, Chief Executive Officer of Curio Wellness. “Vireo has a strong track record in the New York market, and we’re confident they are the right partner to uphold the integrity of our products and deliver them to a broader audience.”
The first Curio-branded products are expected to launch in licensed New York dispensaries in Q4 2025.
About Curio Wellness
Curio Wellness is a cGMP-certified, vertically integrated cannabis company dedicated to developing, producing, and distributing innovative health and wellness products. Through science, integrity, and wellness-centered design, Curio empowers patients and adult-use consumers with trusted products that fit into a lifestyle of intention and care.
About Vireo Growth Inc.
Vireo was founded in 2014 as a medical cannabis pioneer. Vireo operates with a long-term mindset, a bias for action, and an unapologetic commitment to its customers, employees, shareholders, industry collaborators, and the communities it calls home.
Related Articles:
